Ralaniten triacetate
Ralaniten triacetate (EPI-506), a precursor of Ralaniten, is a first-of-its-kind, orally active androgen receptor N-terminal structural domain (AR-NTD) inhibitor with anticancer activity and can be used to study prostate and breast cancer.
Product Specifications
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
521
Molecular Formula
C27H33ClO8
Notes
Research use only, not for human use.
Receptor
Androgen Receptor
CAS Number
1637573-04-6
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items